MedTrace Logo

Speech-based Digital Biomarker for Psychiatric Disease

NCT04851912 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-09-27

No results posted yet for this study

Summary

The general objectives of this study are to build a proof-of-concept, speech-based, digital biomarker for identifying the presence and tracking the severity of psychiatric disease.

Conditions

  • Speech
  • Psychiatric Disorder
  • Language

Interventions

OTHER

Winterlight Apps

Longitudinal speech recordings

Sponsors & Collaborators

  • Winterlight Labs

    lead INDUSTRY

Principal Investigators

  • Jessica Robin, PhD · Clinical Research Director, Winterlight Labs

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-27
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04851912 on ClinicalTrials.gov